Want access to unlimited case records and advanced research tools? Create your free CasePortal account now. No credit card required to register.
Try CasePortal for FreeJ. Elrod finds the district court improperly granted the medical organization’s motion for injunctive relief by staying the effective date of each of the FDA’s actions surrounding “morning after pill” approvals and regulatory modifications. The organization alleges that safety risks have been overlooked, and that doctors sometimes must facilitate abortions when certain women experience complications. The part of the order addressing initial approval of the drug is barred by limitations. The portion relating to the generic approval is vacated, being the organization has not shown injury. Portions concerning the FDA’s decision to not enforce a regulation requiring the drug to be dispensed in person will be stayed during the pendency of the litigation. Vacated in part. Affirmed in part.